Kiklin (bixalomer) / Astellas  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kiklin (bixalomer) / Astellas
NCT00358046: Efficacy and Tolerability of ILY101 in Dialysis Patients With Hyperphosphatemia

Unknown status
2
120
US
ILY101
Ilypsa
Kidney Diseases, Renal Insufficiency
 
 
NCT02753894: Dose Range-finding Study of ASP1585 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia

Completed
2
73
Japan
ASP1585, Bixalomer, Kiklin (R)
Astellas Pharma Inc
Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia
06/08
06/08
NCT00505037: A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis

Completed
2
156
Japan
ASP1585, Placebo, Sevelamer hydrochloride
Astellas Pharma Inc
Hyperphosphatemia, Chronic Kidney Disease
09/08
09/08
NCT00530114: Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia

Completed
2
167
US
AMG 223, Placebo
Amgen
End Stage Renal Disease, Chronic Kidney Disease, Hyperphosphatemic, Kidney Disease
11/08
02/09

Download Options